If you’ve been exploring skincare treatments lately, you’ve probably heard of Rejuran—a popular injectable solution designed to rejuvenate and repair the skin. But where exactly has this treatment been put to the test? Let’s dive into the clinical studies behind Rejuran and uncover the science that supports its growing reputation.
Rejuran, often called the “skin healing booster,” contains polynucleotides (PN) derived from salmon DNA. These molecules are known for their ability to stimulate collagen production, reduce inflammation, and accelerate tissue repair. While its benefits sound impressive, what really matters is the research backing it up. Clinical trials have been conducted in several countries, primarily in Asia, where Rejuran first gained traction. South Korea, a hub for cutting-edge skincare innovation, has been at the forefront of these studies. Institutions like the Seoul National University Hospital and the Korean Dermatological Association have published findings highlighting Rejuran’s effectiveness in improving skin texture, reducing acne scars, and minimizing fine lines.
One study published in the Journal of Cosmetic Dermatology followed participants over six months and reported a significant improvement in skin elasticity and hydration. Another trial in Singapore, conducted by the National Skin Centre, focused on Rejuran’s role in treating post-acne scarring. Patients saw a 40-60% reduction in scar depth after three sessions, with minimal side effects. These results aren’t just limited to Asia, though. Researchers in Europe and the United States have also begun exploring Rejuran’s potential. A recent collaboration between U.S. dermatologists and South Korean scientists found that combining Rejuran with laser treatments enhanced overall skin renewal compared to lasers alone.
But what makes these studies credible? For starters, they’re conducted in controlled environments with strict ethical guidelines. Most trials involve peer-reviewed methodologies and are published in reputable medical journals. Transparency is key—researchers clearly outline sample sizes, study durations, and potential conflicts of interest. For example, a 2022 meta-analysis reviewed data from over 1,200 patients across multiple countries and concluded that Rejuran’s safety profile is “favorable,” with temporary redness or swelling being the most common side effects.
Of course, not all research is created equal. Some critics point out that long-term studies (five years or more) are still limited, which is common for newer treatments. However, the existing mid-term data—spanning two to three years—shows sustained benefits for many users. Dermatologists also emphasize that results can vary based on skin type, age, and lifestyle factors. For instance, smokers or individuals with severe sun damage might require additional sessions to achieve optimal outcomes.
If you’re curious about trying Rejuran, consult a licensed provider who can explain the science and tailor the treatment to your needs. And if you’d like to explore more about skincare innovations, fillersfairy.com offers a wealth of resources, from expert guides to real-user experiences. Just remember, while Rejuran’s clinical studies are promising, staying informed and setting realistic expectations is the best way to navigate the world of aesthetic treatments.
Looking ahead, researchers are investigating how Rejuran could aid in wound healing and even support hair restoration. As the body of evidence grows, so does our understanding of how polynucleotides can revolutionize skincare. For now, the takeaway is clear: Rejuran isn’t just a trend—it’s a scientifically grounded option for those seeking healthier, more resilient skin.
